Ropes & Gray has represented Bain Capital in the US $489 million sale of Feixiang Chemicals (Zhangjiagang) Co., Ltd., a PRC-based specialty chemical manufacturer, to Rhodia S.A. The transaction received PRC governmental approval and closed Nov. 30.
The deal is the latest high-profile private equity transaction handled by Ropes & Gray in Hong Kong. In October, Hong Kong-based teams of Ropes & Gray attorneys represented TPG in its investment in China Vogue Casualwear, a Shishi, China-based distributor and retailer of casual wear under the brand name Sisulan, and the NYSE IPO of ShangPharma, a TPG portfolio company based in Shanghai that provides chemistry resource outsourcing services to global pharmaceutical and biotech companies.
With one of the leading private equity practices in the world, Ropes & Gray’s lawyers have been involved in some of the most significant private equity deals of 2010, including representing TPG it its $3 billion acquisition of J.Crew Group, Inc.; Bain Capital in its $1.8 billion acquisition of Gymboree Corporation; a private equity consortium consisting of Berkshire Partners, Bain Capital and Advent International in the $1.1 billion leveraged buyout of SkillSoft; TPG in a co-investment with Goldman Sachs for the €1.2 billion secondary buyout acquisition of Ontex N.V.; and Thomas H. Lee Partners in its $1.1 billion acquisition of inVentiv Health.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.